Brief: Armata Pharmaceuticals Reports Q3 2020 Results
12/11/2020 21:37
Nov 12 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2020
RESULTS AND
PROVIDES GENERAL CORPORATE UPDATE
* Q3 REVENUE $300,000
* Q3 REVENUE ESTIMATE $583,000 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn2bBcKxa
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles